This study investigates the safety and how well people tolerate an investigational monoclonal antibody. A monoclonal antibody is a type of protein made in the laboratory that can bind to substances in the body, including cancer cells. The purpose of this study is to learn more about how safe the investigational medication is and how well it is tolerated by participants.

Participants in the study will receive the investigational monoclonal antibody. The study will monitor participants for any side effects and measure how their bodies respond to the treatment. This helps researchers understand the safety and tolerance levels of the investigational medication.

• Who can participate: Participants must meet specific eligibility criteria, including age and health status, which will be detailed by the study coordinators.
• Study details: The study will provide unique insights into the safety and tolerance of the investigational monoclonal antibody through detailed monitoring of participant responses.